Oncology
 |
|
26 march 2020 09:02:33 |
| ALPINE: zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (Future Oncology) |
|
Tweet Future Oncology, Volume 16, Issue 10, Page 517-523, April 2020. |
| 195 viewsCategory: Oncology |
 KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC (Future Oncology)Clinicopathological study of organ metastasis in endometrial cancer (Future Oncology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
